Trial Profile
A Single Dose, Randomized, Open-label, 2-Period, 2-way Crossover, Bioequivalence Study of Sirolimus Granules and Sirolimus Tablets in Japanese Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2019
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis; Fibroma; Kasabach-Merritt syndrome; Lymphangioleiomyomatosis; Renal transplant rejection; Systemic lupus erythematosus
- Focus Pharmacodynamics
- Sponsors Nobelpharma
- 21 Feb 2019 Status changed to completed.
- 12 Dec 2018 New trial record